RE-BVS – Piemonte Repository

Sfoglia per AUTORE
TRAVERSO E
Collezione AOU Alessandria

Items : 6

Cartoon: multicenter prospective observational study of Cardiovascular Toxicity of Trifluridine/Tipiracil in metastatic colorectal cancer. in The oncologist / Oncologist. 2025 Jul 4;30(7):oyaf178. doi: 10.1093/oncolo/oyaf178.

2025
ASL Biella
ASL VCO
AOU Alessandria

Nepote A; Parlagreco E; Traverso ES; Salerno F; Tober N; Laface R; Sperti E; Brizzi MP; Forti LG; Paris MK; Crivelli F; Fiamma V; Leone F; Giuli A; Bonessio E; Nicolì E; Bertola B; Montagnani F;

Bulky Isolated Adrenal Metastasis as First Presentation of Occult Hepatocellular Carcinoma (HCC) in a Patient with a Synchronous Squamous Carcinoma of the Tongue. in Endocrine, metabolic & immune disorders drug targets / Endocr Metab Immune Disord Drug Targets. 2024 Oct 10. doi: 10.2174/0118715303337748240910093934.

2024
AOU Alessandria

Lodin M; Ragni A; Renzelli V; Rossi M; Traverso ES; Gallo M;

The hospital care of patients with cancer: a retrospective analysis of the characteristics of their hospital stay in comparison with other medical conditions. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Nov;139:99-106. doi: 10.1016/j.ejca.2020.08.023. Epub 2020 Sep 24.

2020
AOU Alessandria

Numico G; Zanelli C; Ippoliti R; Rossi M; Traverso E; Antonuzzo A; Bellini R;

Expression levels of circulating miRNAs as biomarkers during multimodal treatment of rectal cancer - TiMiSNAR-mirna: a substudy of the TiMiSNAR Trial (NCT03962088). in Trials / Trials. 2020 Jul 25;21(1):678. doi: 10.1186/s13063-020-04568-9.

2020
AOU Alessandria

Monsellato I; Garibaldi E; Cassinotti E; Baldari L; Boni L; Elmore U; Delpini R; Rosati R; Perinotti R; Alongi F; Bertocchi E; Gori S; Ruffo G; Pernazza G; Pulighe F; De Nisco C; Morpurgo E; Contardo T; Mammano E; Perna F; Menegatti B; Coratti A; Buccianti P; Balestri R; Ceccarelli C; Cavaliere D; Solaini L; Ercolani G; Traverso E; et alii...

Correction to: Standard (8?weeks) vs long (12?weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). in BMC cancer / BMC Cancer. 2020 Feb 17;20(1):128. doi: 10.1186/s12885-020-6632-y.

2020
AOU Alessandria
AOU Novara

Numico G; Franzone P; Priora F; Fusco V; Rossi M; Traverso E; Ercolani G; Cavaliere D; Solaini L; Torri V; Ceccarelli C; Balestri R; Buccianti P; Baroffio P; Gentilli S; Coratti A; Menegatti B; Perna F; Rosati R; Delpini R; Mammano E; Elmore U; Contardo T; Perinotti R; Morpurgo E; De Nisco C; Pulighe F; Pernazza G; Boni L; et alii...

Standard (8?weeks) vs long (12?weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). in BMC cancer / BMC Cancer. 2019 Dec 16;19(1):1215. doi: 10.1186/s12885-019-6271-3.

2019
AOU Alessandria
AOU Novara